Flagship merger ‘effectively scrapped’ after ‘wasting millions’

6th july 2016 hsj roundtable002

The leader of a flagship ‘hub and spoke’ pathology merger has criticised regulators after the project was effectively dropped due to delays in receiving £31m of capital that was allocated to the scheme in 2018.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here